Literature DB >> 7570862

Visceral leishmaniasis in Somalia: prevalence of markers of infection and disease manifestations in a village in an endemic area.

S A Shiddo1, A Aden Mohamed, H O Akuffo, K A Mohamud, A A Herzi, H Herzi Mohamed, G Huldt, L A Nilsson, O Ouchterlony, R Thorstensson.   

Abstract

Prevalence and disease manifestations of visceral leishmaniasis (VL) were studied in a Somali village in an area which has long been known to be endemic for VL. Demographic data were collected from 102 households, comprising 438 inhabitants. Clinical examination was performed of 306 individuals, 72% of the 426 eligible persons. Of these, 276 (90%) agreed to give blood and 246 (80%) to be skin tested with leishmanin. Leishmanin reactions were positive; in 26% anti-Leishmania antibodies were detected in 11%, and splenomegaly was recorded in 14% (23% of those who were seropositive). Malaria was hypoendemic and therefore unlikely to be responsible for more than 10% of the cases with splenomegaly. Three of the seropositive villagers with splenomegaly complained of feeling ill. The remaining 91 sero- and/or leishmanin-positive individuals had no complaint regarding their health and had not experienced any long period of illness. There was a slight over-representation of males in the group of sero- and/or leishmanin-positive villagers, possibly due to a gender-associated difference in exposure to the parasite. Among the patients with clinical VL treated at Mogadishu hospitals during 1989 and 1990, the male/female ratio was 3.3:1, which may indicate a selection of male patients for hospital care. Most patients were < or = 15 years old, suggesting that the highest risk of becoming clinically ill was among children.

Entities:  

Mesh:

Year:  1995        PMID: 7570862     DOI: 10.1016/0035-9203(95)90008-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

Review 1.  Sex hormones and modulation of immunity against leishmaniasis.

Authors:  Heidi Snider; Claudio Lezama-Davila; James Alexander; Abhay R Satoskar
Journal:  Neuroimmunomodulation       Date:  2009-02-11       Impact factor: 2.492

2.  Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp.

Authors:  Bruno L Travi; Yaneth Osorio; Peter C Melby; Bysani Chandrasekar; Lourdes Arteaga; Nancy G Saravia
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 3.  Leishmaniasis Beyond East Africa.

Authors:  Caitlin M Jones; Susan C Welburn
Journal:  Front Vet Sci       Date:  2021-02-26

4.  Visceral leishmaniasis: Clinical and demographic features in an African population.

Authors:  Abdelsalam M Nail; Abdelmageed M Imam
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

Review 5.  Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.

Authors:  Temmy Sunyoto; Julien Potet; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2017-03-09

6.  Pulmonary involvement in human visceral leishmaniasis: Clinical and tomographic evaluation.

Authors:  Ana Jovina Barreto Bispo; Maria Luiza Dória Almeida; Roque Pacheco de Almeida; José Bispo Neto; Allan Valadão de Oliveira Brito; Camila Mendonça França
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

7.  Diversity and Seasonal Dynamics of Ticks on Ring-Tailed Coatis Nasua nasua (Carnivora: Procyonidae) in Two Urban Areas from Midwestern Brazil.

Authors:  Livia Perles; Thiago Fernandes Martins; Wanessa Teixeira Gomes Barreto; Gabriel Carvalho de Macedo; Heitor Miraglia Herrera; Luis Antônio Mathias; Marcelo Bahia Labruna; Darci Moraes Barros-Battesti; Rosangela Zacarias Machado; Marcos Rogério André
Journal:  Animals (Basel)       Date:  2022-01-25       Impact factor: 2.752

8.  Epidemiology and clinical features of patients with visceral leishmaniasis treated by an MSF clinic in Bakool region, Somalia, 2004-2006.

Authors:  Marie-Eve Raguenaud; Anna Jansson; Veerle Vanlerberghe; Geert Van der Auwera; Stijn Deborggraeve; Jean-Claude Dujardin; Giannos Orfanos; Tony Reid; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2007-10-31

9.  Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia.

Authors:  Bart Ostyn; Epco Hasker; Thomas P C Dorlo; Suman Rijal; Shyam Sundar; Jean-Claude Dujardin; Marleen Boelaert
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.